These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25792942)

  • 61. Impact of gender on outcomes in chronic systolic heart failure.
    Ng AC; Wong HS; Yong AS; Sindone AP
    Int J Cardiol; 2007 Apr; 117(2):214-21. PubMed ID: 17064798
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monitoring of ventilation during the early part of cardiopulmonary exercise testing: the first step to detect central sleep apnoea in chronic heart failure.
    Roche F; Maudoux D; Jamon Y; Barthelemy JC
    Sleep Med; 2008 May; 9(4):411-7. PubMed ID: 17761455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [What underlies NYHA class in elderly patients with heart failure? Role of diastolic dysfunction, functional mitral regurgitation and abnormal ventilation during exercise].
    Malfatto G; Cuoccio P; Bizzi C; Branzi G; Villani A; Della Rosa F; Parati G; Facchini M
    Monaldi Arch Chest Dis; 2009 Jun; 72(2):84-90. PubMed ID: 19947190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes].
    Stolbova SK; Dragomiretskaya NA; Beliaev IG; Podzolkov VI
    Kardiologiia; 2020 Jun; 60(5):920. PubMed ID: 32515709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure.
    Ponikowski P; Chua TP; Piepoli M; Banasiak W; Anker SD; Szelemej R; Molenda W; Wrabec K; Capucci A; Coats AJ
    Am J Cardiol; 1998 Aug; 82(3):338-44. PubMed ID: 9708664
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma Amino Acid Abnormalities in Chronic Heart Failure. Mechanisms, Potential Risks and Targets in Human Myocardium Metabolism.
    Aquilani R; La Rovere MT; Corbellini D; Pasini E; Verri M; Barbieri A; Condino AM; Boschi F
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29140312
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
    Dargie HJ; Hildebrandt PR; Riegger GA; McMurray JJ; McMorn SO; Roberts JN; Zambanini A; Wilding JP
    J Am Coll Cardiol; 2007 Apr; 49(16):1696-704. PubMed ID: 17448371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflammatory mediators in chronic heart failure in North India.
    Fedacko J; Singh RB; Gupta A; Hristova K; Toda E; Kumar A; Saxena M; Baby A; Singh R; Toru T; Wilson DW
    Acta Cardiol; 2014 Aug; 69(4):391-8. PubMed ID: 25181914
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
    de Boer RA; Henning RH; Suurmeijer AJ; Pinto YM; Olthof E; Kirkels JH; van Gilst WH; Crijns HJ; van Veldhuisen DJ
    Int J Cardiol; 2001 Mar; 78(1):5-12. PubMed ID: 11259807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Health-related quality of life in Swedish men and women with early rheumatoid arthritis.
    West E; Wållberg-Jonsson S
    Gend Med; 2009 Dec; 6(4):544-54. PubMed ID: 20114005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comprehensive rehabilitation in chronic heart failure--better psycho-emotional status related to quality of life, brain natriuretic peptide concentrations, and clinical severity of disease.
    Laederach-Hofmann K; Roher-Gübeli R; Messerli N; Meyer K
    Clin Invest Med; 2007; 30(2):E54-62. PubMed ID: 17716542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
    D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
    J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure.
    Peeters P; Mets T
    J Gerontol A Biol Sci Med Sci; 1996 Jul; 51(4):M147-51. PubMed ID: 8680996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure.
    Szyguła-Jurkiewicz B; Zakliczyński M; Owczarek A; Partyka R; Mościński M; Pudlo R; Kaczmarczyk M; Zembala M; Poloński L
    Kardiochir Torakochirurgia Pol; 2014 Sep; 11(3):283-8. PubMed ID: 26336436
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Health-Related Quality of Life and Associated Factors Among Adult Patients with Heart Failure in Wolaita Zone Governmental Hospitals, Southern Ethiopia.
    Molla S; Yitayal M; Amare G
    Risk Manag Healthc Policy; 2021; 14():263-271. PubMed ID: 33519251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.